Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16
IRVINE, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products today announced that it will participate in the 14th
Annual Craig-Hallum Alpha Select Conference on November 16, 2023, at the Sheraton New York Times Square Hotel in New York City. Zackary Irani, Chief Executive Officer of Biomerica
will be hosting meetings during the event, which consists of one-on-one and small group meetings.
About Biomerica (NASDAQ: BMRA)
Biomerica, Inc. (www.biomerica.com) is a global biomedical technology company that develops, patents, manufactures
and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians' offices) and in hospital/clinical laboratories for detection and/or treatment of
medical conditions and diseases. The Company's products are designed to enhance the health and well-being of people, while reducing total healthcare costs. Biomerica is primarily focused on
gastrointestinal and inflammatory diseases where the Company has multiple diagnostic and therapeutic products in development.
Corporate Contact:
Zack Irani
949-645-2111
investors@biomerica.com
Lesen Sie auch
Source: Biomerica, Inc.